Endocrinology and Nutrition Department, University Hospital Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain.
Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain.
Front Endocrinol (Lausanne). 2020 Dec 10;11:574312. doi: 10.3389/fendo.2020.574312. eCollection 2020.
Type 1 diabetes is a disease with complex therapeutic recommendations that require day-to-day lifestyle changes. Motivational Interviewing is a communication tool that has proved effective in changing behaviors in people with addictions, obesity and type 2 diabetes. Our objective is to evaluate the effects of a Motivational Interviewing intervention in people with type 1 diabetes.
Sixty-six patients with type 1 diabetes and hemoglobin A1c >= 8% have been included and randomly assigned (computer-generated sequence, sealed envelopes, ratio 1:1) either to the intervention or to the control group. In the intervention group, appointments every 4 months with the endocrinologist include Motivational Interviewing; in the control group, the appointments proceed as usual. Patients will be followed for 16 months. The primary outcome will be self-care behaviors, assessed by a validated questionnaire, the Diabetes Self-Care Inventory-Revised Version. Secondary outcomes include: HbA1c, motivation for self-care, self-efficacy, health-related quality of life, satisfaction with professional-patient relationship, and fulfillment of patients' own objectives. The practitioners receive training in Motivational Interviewing in order to help them promote adherence to self-care, encourage patient motivation and improve the doctor-patient relationship. The Motivational Interviewing intervention will be evaluated by two psychologists, blinded to the assigned treatment, through video recordings of the sessions and the administration of a purpose-built questionnaire, the EVEM 2.0 scale.
There is evidence that MI can improve self-care in type 2 diabetes. In this study, we aim to evaluate the effect of MI on self-care and HbA1c in people with type 1 diabetes.
https://clinicaltrials.gov/ct2/show/NCT03906786, identifier NCT03906786.
1 型糖尿病是一种具有复杂治疗建议的疾病,需要日常的生活方式改变。动机性访谈是一种沟通工具,已被证明在改变成瘾、肥胖和 2 型糖尿病患者的行为方面有效。我们的目标是评估动机性访谈干预对 1 型糖尿病患者的效果。
共纳入 66 例糖化血红蛋白(HbA1c)≥8%的 1 型糖尿病患者,采用计算机生成序列、密封信封、比例 1:1 随机分配至干预组或对照组。在干预组中,每 4 个月与内分泌医生预约时进行动机性访谈;对照组则按常规进行预约。患者将随访 16 个月。主要结局指标为经过验证的问卷,即糖尿病自我护理量表修订版评估的自我护理行为。次要结局指标包括:HbA1c、自我护理动机、自我效能、健康相关生活质量、对医患关系的满意度以及患者自身目标的实现。医生接受动机性访谈培训,以帮助他们促进自我护理的依从性、鼓励患者的动机并改善医患关系。动机性访谈干预将由两位心理学家通过会议录像和专门设计的问卷(EVEM 2.0 量表)进行评估,他们对分配的治疗方案不知情。
有证据表明 MI 可以改善 2 型糖尿病的自我护理。在这项研究中,我们旨在评估 MI 对 1 型糖尿病患者自我护理和 HbA1c 的影响。
https://clinicaltrials.gov/ct2/show/NCT03906786,标识符 NCT03906786。